NBIX
NASDAQ · Biotechnology
Neurocrine Biosciences Inc
$131.13
+3.27 (+2.56%)
Performance
1D
—
1W
—
1M
—
3M
-9.73%
6M
-6.52%
1Y
+14.57%
YTD
-6.74%
Open$128.98
Previous Close$127.86
Day High$133.05
Day Low$128.98
52W High$160.18
52W Low$84.23
Volume—
Avg Volume832.1K
Market Cap12.75B
P/E Ratio26.63
EPS$4.66
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$139.44
Below
SMA 200
$135.94
Below
RSI (14)
38.6
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
36 analysts
Price Target
-3.2% upside
Current
$131.13
$131.13
Target
$126.93
$126.93
$104.30
$126.93 avg
$177.55
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 2.79B | 2.24B | 5.53B |
| Net Income | 466.09M | 337.42M | 497.45M |
| Profit Margin | 16.7% | 15.9% | 9.0% |
| EBITDA | 628.24M | 480.08M | 909.27M |
| Free Cash Flow | — | — | 422.12M |
| Rev Growth | +24.3% | +24.3% | -8.7% |
| Debt/Equity | — | — | 0.48 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $207.18 | +0.96% | 166.6 | 397.77B |
| AMGN | Amgen Inc | $353.93 | +1.58% | 24.4 | 188.06B |
| GILD | Gilead Sciences Inc | $138.26 | +0.11% | 20.0 | 170.34B |
| VRTX | Vertex Pharmaceuticals Inc | $454.97 | +1.42% | 29.2 | 115.53B |
| REGN | Regeneron Pharmaceuticals | $749.47 | +1.05% | 17.9 | 80.50B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.70 | +6.70% | 139.7 | 43.84B |